RichardAAdamsMD

PubMed

• Pharmacogenetic Analyses of 2183 Patients with Advanced Colorectal Cancer; Potential Role for Common Dihydropyrimidine Dehydrogenase Variants in Toxicity to Chemotherapy
  Richard Adams, MD> ;European Journal of Cancer.
• Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials fr...
  Franko J, Shi Q, Meyers JP, Maughan TS, Adams RA, Seymour MT, Saltz L, Punt CJA, Koopman M, Tournigand C, Tebbutt NC, Diaz-Rubio E, Souglakos J, Falcone A, Chibaudel B...> ;Lancet Oncol.. 2016-12-01
• Initial Results from the Royal College of Radiologists' UK National Audit of Anal Cancer Radiotherapy 2015.
  Muirhead R, Drinkwater K, O'Cathail SM, Adams R, Glynne-Jones R, Harrison M, Hawkins MA, Sebag-Montefiore D, Gilbert DC> ;Clin Oncol (R Coll Radiol). 2016-10-31
• Wide Variation in the Use of Radiotherapy in the Management of Surgically Treated Rectal Cancer Across the English National Health Service.
  Morris EJA, Finan PJ, Spencer K, Geh I, Crellin A, Quirke P, Thomas JD, Lawton S, Adams R, Sebag-Montefiore D> ;Clin Oncol (R Coll Radiol). 2016-08-01
• Anal cancer: developing an intensity-modulated radiotherapy solution for ACT2 fractionation.
  Muirhead R, Adams RA, Gilbert DC, Glynne-Jones R, Harrison M, Sebag-Montefiore D, Hawkins MA> ;Clin Oncol (R Coll Radiol). 2014-11-01
• Image-guided radiotherapy for rectal cancer: a systematic review.
  Gwynne S, Webster R, Adams R, Mukherjee S, Coles B, Staffurth J> ;Clin Oncol (R Coll Radiol). 2012-05-01
• Imaging for target volume delineation in rectal cancer radiotherapy--a systematic review.
  Gwynne S, Mukherjee S, Webster R, Spezi E, Staffurth J, Coles B, Adams R> ;Clin Oncol (R Coll Radiol). 2012-02-01
• Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis.
  Vale, C.L., Tierney, J.F., Fisher, D., Adams, R.A., Kaplan, R., Maughan, T.S., Parmar, M.B., Meade, A.M.> ;Cancer Treat Rev. 2012 Oct
• A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network.
  Shaw PHS, Adams R, Jordan C, Crosby TDL> ;Clin Oncol (R Coll Radiol). 2007-02-01
• Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN ...
  Maughan, T. S., Adams, R. A., Smith, C. G., Meade, A. M., Seymour, M. T., Wilson, R. H., Idziaszczyk, S., Harris, R., Fisher, D., Kenny, S. L., Kay, E., Mitchell, J. K...> ;Lancet. 2011 Jun 18
• Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomi...
  Adams, R. A., Meade, A. M., Seymour, M. T., Wilson, R. H., Madi, A., Fisher, D., Kenny, S. L., Kay, E., Hodgkinson, E., Pope, M., Rogers, P., Wasan, H., Falk, S., Goll...> ;Lancet Oncol. 2011 Jul
• Where now for anti-EGF receptor therapies in colorectal cancer?
  Shaw, P. H., Adams, R. A.> ;Expert Rev Anticancer Ther. 2011 Oct
• Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC COIN trial experience.
  Adams, R. A., Meade, A. M., Madi, A., Fisher, D., Kay, E., Kenny, S., Kaplan, R. S., Maughan, T. S.> ;Br J Cancer. 2009 Jan 27
• Join now to see all